Updates in Molluscum Contagiosum Management

Click the cover to access the full digital edition of Updates in Molluscum Contagiosum Management

J Clin Aesthet Dermatol 2023;16(8 Suppl 1)

Molluscum Contagiosum: Epidemiology, Considerations, Treatment Options, and Therapeutic Gaps
by Adelaide A. Hebert, MD; Neal Bhatia, MD; and James Q. Del Rosso, DO

Comprehensive Management of Molluscum Contagiosum: Assessment of Clinical Associations, Comorbidities, and Management Principles
by Neal Bhatia, MD; Adelaide A. Hebert, MD; and James Q. Del Rosso, DO

Guidance on Documentation and Coding for Molluscum Contagiosum
by Daniel M. Siegel, MD, and Leon Kircik, MD

Clinical and Legal Considerations in Pharmaceutical Compounding
by Leon Kircik, MD, and Daniel M. Siegel, MD

 

Share:

Recent Articles:

Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case
Letters to the Editor: September 2025
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-Q
Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease

Categories:

Recent Articles:

Peter Lio, MD: Updates in AD and Diet
Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case
Letters to the Editor: September 2025
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-Q